Cross-reactivity of amino acids and other compounds in the biuret reaction: Interference with urinary peptide measurements

被引:38
作者
Hortin, GL [1 ]
Meilinger, B [1 ]
机构
[1] NIH, Warren G Magnuson Clin Ctr, Dept Lab Med, Bethesda, MD 20892 USA
关键词
D O I
10.1373/clinchem.2005.052019
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Biuret assays for total protein measurement are considered to react with all peptides longer than 2 residues. Some studies using biuret assays of urine suggest that small peptides generally are more abundant than proteins in urine, but it is not clear whether this is a problem of assay specificity. Methods: We analyzed the specificity and kinetics of a biuret reaction for solutions of amino acids, organic compounds, peptides, proteins, and ultrafiltered urine specimens and compared the results with standard clinical assays for protein measurement. Results: The biuret assay cross-reacted with several amino acids, dipeptides, and other organic compounds able to form 5- or 6-member ring chelation complexes with copper. Reactions with amino acids and dipeptides had higher absorbance maxima (blue color) than with larger peptides and proteins (purple). Compounds forming potential 4-, 7-, 8-, or 9-member ring complexes with copper had low reactivity. Amino acid amides, dipeptides, and longer peptides had substantial reactivity, except those containing proline. Proteins and polypeptides had similar biuret reactivities per peptide bond, but reaction kinetics were slower for proteins than peptides. Urine specimens ultrafiltered through 3-kDa-cutoff membranes had substantial biuret reactivity, but absorbance maxima were consistent with cross-reactive amino acids rather than peptides. Conclusions: Many compounds, including amino acids, amino acid derivatives, and dipeptides, cross-react in biuret assays. Our studies improve understanding of the specificity of endpoint and kinetic biuret assays widely used in clinical laboratories. Amino acids, urea, and creatinine contribute to overestimation of urinary peptide content by biuret assays. (c) 2005 American Association for Clinical Chemistry.
引用
收藏
页码:1411 / 1419
页数:9
相关论文
共 40 条
[1]  
Africk, 1989, BIOCHEM GENET
[2]  
Borsook H, 1932, J BIOL CHEM, V98, P671
[3]   Characterization of renal allograft rejection by urinary proteomic analysis [J].
Clarke, W ;
Silverman, BC ;
Zhang, Z ;
Chan, DW ;
Klein, AS ;
Molmenti, EP .
ANNALS OF SURGERY, 2003, 237 (05) :660-664
[4]   The application of clinical proteomics to cancer and other diseases [J].
Clarke, W ;
Zhang, Z ;
Chan, DW .
CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2003, 41 (12) :1562-1570
[5]  
DOETSCH K, 1975, CLIN CHEM, V21, P778
[6]  
ECKFELDT JH, 1984, CLIN CHEM, V30, P443
[7]  
GLASSOCK RJ, 2001, MASSRY GLASSOCKS TXB, P545
[8]  
GORNALL AG, 1949, J BIOL CHEM, V177, P751
[9]  
Greive KA, 2001, CLIN CHEM, V47, P1717
[10]  
Hampel DJ, 2001, J AM SOC NEPHROL, V12, P1026, DOI 10.1681/ASN.V1251026